Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular Imaging

Molecular imaging used in cancer diagnosis and therapeutic response monitoring is important for glioblastoma (GBM) research. Antiangiogenic therapy currently is one of the emerging approaches for GBM treatment. In this study, a multifunctional nanoparticle was fabricated that can facilitate the fluo...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaqian Li, Yang Du, Xia Liu, Qian Zhang, Lijia Jing, Xiaolong Liang, Chongwei Chi, Zhifei Dai, Jie Tian
Format: Article
Language:English
Published: SAGE Publishing 2015-07-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2015.00014
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850088615980302336
author Yaqian Li
Yang Du
Xia Liu
Qian Zhang
Lijia Jing
Xiaolong Liang
Chongwei Chi
Zhifei Dai
Jie Tian
author_facet Yaqian Li
Yang Du
Xia Liu
Qian Zhang
Lijia Jing
Xiaolong Liang
Chongwei Chi
Zhifei Dai
Jie Tian
author_sort Yaqian Li
collection DOAJ
description Molecular imaging used in cancer diagnosis and therapeutic response monitoring is important for glioblastoma (GBM) research. Antiangiogenic therapy currently is one of the emerging approaches for GBM treatment. In this study, a multifunctional nanoparticle was fabricated that can facilitate the fluorescence imaging of tumor and deliver a therapeutic agent to the tumor region in vivo and therefore possesses broad application in cancer diagnosis and treatment. This particle was polylactic acid (PLA) nanoparticles encapsulating Endostar, which was further conjugated with GX1 peptide and the near-infrared (NIR) dye IRDye 800CW (IGPNE). We demonstrated noninvasive angiogenesis targeting and therapy of IGPNE on U87MG xenografts in vivo using dual-modality optical molecular imaging including NIR fluorescence molecular imaging (FMI) and bioluminescence imaging (BLI). The NIR FMI results demonstrated that IGPNE had more accumulation to the tumor site compared to free IRDye 800CW. To further evaluate the antitumor treatment efficacy of IGPNE, BLI and immunohistochemistry analysis were performed on tumor-bearing mice. With the aid of molecular imaging, the results confirmed that IGPNE enhanced antitumor treatment efficacy compared to free Endostar. In conclusion, IGPNE realizes real-time imaging of U87MG tumors and improves the antiangiogenic therapeutic efficacy in vivo.
format Article
id doaj-art-7de60cc25e8b4f24931db1a63af96503
institution DOAJ
issn 1536-0121
language English
publishDate 2015-07-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-7de60cc25e8b4f24931db1a63af965032025-08-20T02:42:59ZengSAGE PublishingMolecular Imaging1536-01212015-07-011410.2310/7290.2015.0001410.2310_7290.2015.00014Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular ImagingYaqian LiYang DuXia LiuQian ZhangLijia JingXiaolong LiangChongwei ChiZhifei DaiJie TianMolecular imaging used in cancer diagnosis and therapeutic response monitoring is important for glioblastoma (GBM) research. Antiangiogenic therapy currently is one of the emerging approaches for GBM treatment. In this study, a multifunctional nanoparticle was fabricated that can facilitate the fluorescence imaging of tumor and deliver a therapeutic agent to the tumor region in vivo and therefore possesses broad application in cancer diagnosis and treatment. This particle was polylactic acid (PLA) nanoparticles encapsulating Endostar, which was further conjugated with GX1 peptide and the near-infrared (NIR) dye IRDye 800CW (IGPNE). We demonstrated noninvasive angiogenesis targeting and therapy of IGPNE on U87MG xenografts in vivo using dual-modality optical molecular imaging including NIR fluorescence molecular imaging (FMI) and bioluminescence imaging (BLI). The NIR FMI results demonstrated that IGPNE had more accumulation to the tumor site compared to free IRDye 800CW. To further evaluate the antitumor treatment efficacy of IGPNE, BLI and immunohistochemistry analysis were performed on tumor-bearing mice. With the aid of molecular imaging, the results confirmed that IGPNE enhanced antitumor treatment efficacy compared to free Endostar. In conclusion, IGPNE realizes real-time imaging of U87MG tumors and improves the antiangiogenic therapeutic efficacy in vivo.https://doi.org/10.2310/7290.2015.00014
spellingShingle Yaqian Li
Yang Du
Xia Liu
Qian Zhang
Lijia Jing
Xiaolong Liang
Chongwei Chi
Zhifei Dai
Jie Tian
Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular Imaging
Molecular Imaging
title Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular Imaging
title_full Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular Imaging
title_fullStr Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular Imaging
title_full_unstemmed Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular Imaging
title_short Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular Imaging
title_sort monitoring tumor targeting and treatment effects of irdye 800cw and gx1 conjugated polylactic acid nanoparticles encapsulating endostar on glioma by optical molecular imaging
url https://doi.org/10.2310/7290.2015.00014
work_keys_str_mv AT yaqianli monitoringtumortargetingandtreatmenteffectsofirdye800cwandgx1conjugatedpolylacticacidnanoparticlesencapsulatingendostarongliomabyopticalmolecularimaging
AT yangdu monitoringtumortargetingandtreatmenteffectsofirdye800cwandgx1conjugatedpolylacticacidnanoparticlesencapsulatingendostarongliomabyopticalmolecularimaging
AT xialiu monitoringtumortargetingandtreatmenteffectsofirdye800cwandgx1conjugatedpolylacticacidnanoparticlesencapsulatingendostarongliomabyopticalmolecularimaging
AT qianzhang monitoringtumortargetingandtreatmenteffectsofirdye800cwandgx1conjugatedpolylacticacidnanoparticlesencapsulatingendostarongliomabyopticalmolecularimaging
AT lijiajing monitoringtumortargetingandtreatmenteffectsofirdye800cwandgx1conjugatedpolylacticacidnanoparticlesencapsulatingendostarongliomabyopticalmolecularimaging
AT xiaolongliang monitoringtumortargetingandtreatmenteffectsofirdye800cwandgx1conjugatedpolylacticacidnanoparticlesencapsulatingendostarongliomabyopticalmolecularimaging
AT chongweichi monitoringtumortargetingandtreatmenteffectsofirdye800cwandgx1conjugatedpolylacticacidnanoparticlesencapsulatingendostarongliomabyopticalmolecularimaging
AT zhifeidai monitoringtumortargetingandtreatmenteffectsofirdye800cwandgx1conjugatedpolylacticacidnanoparticlesencapsulatingendostarongliomabyopticalmolecularimaging
AT jietian monitoringtumortargetingandtreatmenteffectsofirdye800cwandgx1conjugatedpolylacticacidnanoparticlesencapsulatingendostarongliomabyopticalmolecularimaging